These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 22704597)
1. Overcoming multidrug resistance by co-delivery of Mdr-1 and survivin-targeting RNA with reduction-responsible cationic poly(β-amino esters). Yin Q; Shen J; Chen L; Zhang Z; Gu W; Li Y Biomaterials; 2012 Sep; 33(27):6495-506. PubMed ID: 22704597 [TBL] [Abstract][Full Text] [Related]
2. Multifunctional nanoparticles improve therapeutic effect for breast cancer by simultaneously antagonizing multiple mechanisms of multidrug resistance. Yin Q; Shen J; Zhang Z; Yu H; Chen L; Gu W; Li Y Biomacromolecules; 2013 Jul; 14(7):2242-52. PubMed ID: 23682680 [TBL] [Abstract][Full Text] [Related]
3. Co-delivery of doxorubicin and RNA using pH-sensitive poly (β-amino ester) nanoparticles for reversal of multidrug resistance of breast cancer. Tang S; Yin Q; Zhang Z; Gu W; Chen L; Yu H; Huang Y; Chen X; Xu M; Li Y Biomaterials; 2014 Jul; 35(23):6047-59. PubMed ID: 24797883 [TBL] [Abstract][Full Text] [Related]
4. Reversal of multidrug resistance by reduction-sensitive linear cationic click polymer/iMDR1-pDNA complex nanoparticles. Gao Y; Chen L; Zhang Z; Chen Y; Li Y Biomaterials; 2011 Feb; 32(6):1738-47. PubMed ID: 21112086 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of survivin expression and enhanced chemosensitivity of MCF-7 cells to adriamycin by PDMAE/survivin shRNA complex nanoparticles. Yang Y; Gao Y; Chen L; Huang Y; Li Y Int J Pharm; 2011 Feb; 405(1-2):188-95. PubMed ID: 21130850 [TBL] [Abstract][Full Text] [Related]
6. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles. Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793 [TBL] [Abstract][Full Text] [Related]
7. Mesoporous silica nanoparticles loading doxorubicin reverse multidrug resistance: performance and mechanism. Shen J; He Q; Gao Y; Shi J; Li Y Nanoscale; 2011 Oct; 3(10):4314-22. PubMed ID: 21892492 [TBL] [Abstract][Full Text] [Related]
8. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery. Gu J; Fang X; Hao J; Sha X Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500 [TBL] [Abstract][Full Text] [Related]
9. Cationic polymer-mediated small interfering RNA delivery for P-glycoprotein down-regulation in tumor cells. Abbasi M; Lavasanifar A; Berthiaume LG; Weinfeld M; Uludağ H Cancer; 2010 Dec; 116(23):5544-54. PubMed ID: 20715163 [TBL] [Abstract][Full Text] [Related]
10. Restoration of chemosensitivity by multifunctional micelles mediated by P-gp siRNA to reverse MDR. Shen J; Wang Q; Hu Q; Li Y; Tang G; Chu PK Biomaterials; 2014 Oct; 35(30):8621-34. PubMed ID: 25002258 [TBL] [Abstract][Full Text] [Related]
11. Lentivirus-mediated RNA interference reversing the drug-resistance in MDR1 single-factor resistant cell line K562/MDR1. Ye X; Liu T; Gong Y; Zheng B; Meng W; Leng Y Leuk Res; 2009 Aug; 33(8):1114-9. PubMed ID: 19036441 [TBL] [Abstract][Full Text] [Related]
12. Reversal of cancer multidrug resistance by green tea polyphenols. Mei Y; Qian F; Wei D; Liu J J Pharm Pharmacol; 2004 Oct; 56(10):1307-14. PubMed ID: 15482646 [TBL] [Abstract][Full Text] [Related]
13. Redox-responsive nanoparticles from the single disulfide bond-bridged block copolymer as drug carriers for overcoming multidrug resistance in cancer cells. Wang YC; Wang F; Sun TM; Wang J Bioconjug Chem; 2011 Oct; 22(10):1939-45. PubMed ID: 21866903 [TBL] [Abstract][Full Text] [Related]
14. Traceable multifunctional micellar nanocarriers for cancer-targeted co-delivery of MDR-1 siRNA and doxorubicin. Xiong XB; Lavasanifar A ACS Nano; 2011 Jun; 5(6):5202-13. PubMed ID: 21627074 [TBL] [Abstract][Full Text] [Related]
15. Reversal of multidrug resistance of cancer through inhibition of P-glycoprotein by 5-bromotetrandrine. Jin J; Wang FP; Wei H; Liu G Cancer Chemother Pharmacol; 2005 Feb; 55(2):179-88. PubMed ID: 15378274 [TBL] [Abstract][Full Text] [Related]
16. Overcoming multidrug resistance in human carcinoma cells by an antisense oligodeoxynucleotide--doxorubicin conjugate in vitro and in vivo. Ren Y; Wang Y; Zhang Y; Wei D Mol Pharm; 2008; 5(4):579-87. PubMed ID: 18461970 [TBL] [Abstract][Full Text] [Related]
17. Multifunctional QD-based co-delivery of siRNA and doxorubicin to HeLa cells for reversal of multidrug resistance and real-time tracking. Li JM; Wang YY; Zhao MX; Tan CP; Li YQ; Le XY; Ji LN; Mao ZW Biomaterials; 2012 Mar; 33(9):2780-90. PubMed ID: 22243797 [TBL] [Abstract][Full Text] [Related]
18. Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance. Wang F; Zhang D; Zhang Q; Chen Y; Zheng D; Hao L; Duan C; Jia L; Liu G; Liu Y Biomaterials; 2011 Dec; 32(35):9444-56. PubMed ID: 21903258 [TBL] [Abstract][Full Text] [Related]
19. P-glycoprotein antibody functionalized carbon nanotube overcomes the multidrug resistance of human leukemia cells. Li R; Wu R; Zhao L; Wu M; Yang L; Zou H ACS Nano; 2010 Mar; 4(3):1399-408. PubMed ID: 20148593 [TBL] [Abstract][Full Text] [Related]
20. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells. Wang TX; Yang XH Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]